Symeonidis, A.;                     Diamantopoulos, P.;                     Galanopoulos, A.;                     Kourakli, A.;                     Sazakli, E.;                     Hatzimichael, E.;                     Pagoni, M.;                     Zikos, P.;                     Vassilakopoulos, T.P.;                     Gavrilaki, E.;     
    et al.    Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS). Cancers 2025, 17, 1388.
    https://doi.org/10.3390/cancers17091388
    AMA Style
    
                                Symeonidis A,                                 Diamantopoulos P,                                 Galanopoulos A,                                 Kourakli A,                                 Sazakli E,                                 Hatzimichael E,                                 Pagoni M,                                 Zikos P,                                 Vassilakopoulos TP,                                 Gavrilaki E,         
        et al.        Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS). Cancers. 2025; 17(9):1388.
        https://doi.org/10.3390/cancers17091388
    
    Chicago/Turabian Style
    
                                Symeonidis, Argiris,                                 Panagiotis Diamantopoulos,                                 Athanasios Galanopoulos,                                 Alexandra Kourakli,                                 Eleni Sazakli,                                 Eleftheria Hatzimichael,                                 Maria Pagoni,                                 Panagiotis Zikos,                                 Theodoros P. Vassilakopoulos,                                 Eleni Gavrilaki,         
         and et al.        2025. "Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)" Cancers 17, no. 9: 1388.
        https://doi.org/10.3390/cancers17091388
    
    APA Style
    
                                Symeonidis, A.,                                 Diamantopoulos, P.,                                 Galanopoulos, A.,                                 Kourakli, A.,                                 Sazakli, E.,                                 Hatzimichael, E.,                                 Pagoni, M.,                                 Zikos, P.,                                 Vassilakopoulos, T. P.,                                 Gavrilaki, E.,                                 Bouchla, A.,                                 Kioumi, A.,                                 Palla, K.,                                 Kotsianidis, I.,                                 Michali, E.,                                 Kartassis, Z.,                                 Katodritou, E.,                                 Lazaris, V.,                                 Vagia, M.,         
                                            ... Pappa, V., on behalf of the Hellenic [Greek] Myelodysplastic Syndromes Study Group.        
        (2025). Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS). Cancers, 17(9), 1388.
        https://doi.org/10.3390/cancers17091388